The expression profiling of these proteins was consistent with the reported literature, which detected over-expression of ZEB1 [74-77] and ZEB2 [78-80] in human cancers, including lung cancer, prostate cancer, colorectal cancer, and bladder cancer. This evidence concerns the gene ZEB2 and urinary bladder carcinoma.